| Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | Abundance Ratio: (B Stem KO) / (B Stem WT) | Abundance Ratio (log2): (B Stem KO) / (B Stem WT) | Abundance Ratio P-Value: (B Stem KO) / (B Stem WT) | Abundance Ratio Adj. P-Value: (B Stem KO) / (B Stem WT) | Abundance Ratio Variability [%]: (B Stem KO) / (B Stem WT) | Abundances (Grouped): B Stem KO | Abundances (Grouped): B Stem WT | Abundances (Grouped) CV [%]: B Stem KO | Abundances (Grouped) CV [%]: B Stem WT | Abundances (Scaled): F2: 129, Sample, B Stem KO, 1 | Abundances (Scaled): F2: 130, Sample, B Stem KO, 2 | Abundances (Scaled): F2: 131, Sample, B Stem KO, 3 | Abundances (Scaled): F2: 126, Sample, B Stem WT, 1 | Abundances (Scaled): F2: 127, Sample, B Stem WT, 2 | Abundances (Scaled): F2: 128, Sample, B Stem WT, 3 | Abundances (Normalized): F2: 129, Sample, B Stem KO, 1 | Abundances (Normalized): F2: 130, Sample, B Stem KO, 2 | Abundances (Normalized): F2: 131, Sample, B Stem KO, 3 | Abundances (Normalized): F2: 126, Sample, B Stem WT, 1 | Abundances (Normalized): F2: 127, Sample, B Stem WT, 2 | Abundances (Normalized): F2: 128, Sample, B Stem WT, 3 | Abundance: F2: 129, Sample, B Stem KO, 1 | Abundance: F2: 130, Sample, B Stem KO, 2 | Abundance: F2: 131, Sample, B Stem KO, 3 | Abundance: F2: 126, Sample, B Stem WT, 1 | Abundance: F2: 127, Sample, B Stem WT, 2 | Abundance: F2: 128, Sample, B Stem WT, 3 | Abundances Count: F2: 129, Sample, B Stem KO, 1 | Abundances Count: F2: 130, Sample, B Stem KO, 2 | Abundances Count: F2: 131, Sample, B Stem KO, 3 | Abundances Count: F2: 126, Sample, B Stem WT, 1 | Abundances Count: F2: 127, Sample, B Stem WT, 2 | Abundances Count: F2: 128, Sample, B Stem WT, 3 | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Gene Symbol | Chromosome | Reactome Pathways | Ensembl Gene ID | KEGG Pathways | WikiPathways | # Razor Peptides | Modifications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High | Q3UVX5 | Metabotropic glutamate receptor 5 OS=Mus musculus OX=10090 GN=Grm5 PE=1 SV=2 | 0 | 91.112 | 17 | 20 | 34 | 19 | 1203 | 131.8 | 7.84 | 1.032 | 0.05 | 0.891809892 | 0.997204186 | 6.93 | 100.7 | 99.3 | 3.89 | 12.66 | 100.9 | 102.7 | 95.3 | 113.5 | 99.5 | 88.1 | 2138.6 | 2176.5 | 2019 | 2406.1 | 2108.2 | 1868.3 | 1871.4 | 2070.8 | 2019 | 2126.2 | 1969.9 | 1803.5 | 19 | 19 | 19 | 19 | 19 | 19 | cell communication;cell organization and biogenesis;metabolic process;regulation of biological process;response to stimulus | cytoplasm;membrane | protein binding;receptor activity;signal transducer activity | "Pf00003, Pf01094, Pf07562, Pf10606, Pf13458" | 108071 | Grm5 | 7 | Gastrin-CREB signalling pathway via PKC and MAPK; Neurexins and neuroligins; Class C/3 (Metabotropic glutamate/pheromone receptors) | ENSMUSG00000049583.15 | Phospholipase D signaling pathway; Retrograde endocannabinoid signaling; Long-term potentiation; Huntington's disease; Glutamatergic synapse; Calcium signaling pathway; Gap junction; Neuroactive ligand-receptor interaction | "Hypothetical Network for Drug Addiction; Non-odorant GPCRs; GPCRs, Class C Metabotropic glutamate, pheromone" | 1 |